In addition to releasing tumor necrosis factor (TNF-α), IFN-γ, IL-1 and other active substances directly involved in anti-tumor effects, they also regulate the anti-tumor effects of cytotoxic T lymphocytes (CTL) and lymphokine-activated killer cells (LAK), and have a wide range of immune sensing and effector functions. Here, IFNG is linked to neoplasm.